UroGen Pharma Ltd. (URGN)

UroGen Pharma Revenue

UroGen Pharma had revenue of $24.22M in the quarter ending June 30, 2025, with 10.83% growth. This brings the company's revenue in the last twelve months to $94.24M, up 10.85% year-over-year. In the year 2024, UroGen Pharma had annual revenue of $90.40M with 9.29% growth.

• Revenue (ttm): $94.24M
• Revenue Growth: +10.85%
• P/S Ratio: 9.65
• Revenue / Employee: $401,013
• Employees: 235
• Market Cap: 869.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	90.40M	7.69M	9.29%
Dec 31, 2023	82.71M	18.36M	28.52%
Dec 31, 2022	64.36M	16.32M	33.96%
Dec 31, 2021	48.04M	36.24M	307.17%
Dec 31, 2020	11.80M	11.78M	65,450.00%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.